General Announcement::Proposed IPO of Glenmark Life Sciences Limited Filing of draft red herring prospectus

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
17-Apr-2021 03:01:44
Status
New
Announcement Sub Title
Proposed IPO of Glenmark Life Sciences Limited Filing of draft red herring prospectus
Announcement Reference
SG210417OTHRWB2D
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary and Compliance Officer
Effective Date and Time of the event
16/04/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
Proposed Initial Public Offering ( IPO ) of Glenmark Life Sciences Limited Filing of draft red herring prospectus

Attachments

SGX GPL Announcement 16042021.pdf
Total size =212K